Ipsen /
Epizyme
Ipsen completes tender offer for Epizyme, Inc.
- Price per share
- $1.45/share
- Stage
- Agreement signed
What happened
Ipsen S.A. accepted for payment shares tendered in its offer for Epizyme, Inc. The offer price was $1.45 per share, plus a contingent value right tied to specified milestones.
The filing states that Epizyme will continue as a wholly owned indirect subsidiary of Ipsen following the merger.
The source
Everything on this page comes from the source below.
Ipsen completes tender offer for Epizyme, Inc.
This document is the source for the companies, stage, figure and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly